Skip to main content
Clinical Trials/NCT02865603
NCT02865603CompletedNot Applicable

Effectiveness of a Universal Classroom-based Preventive Intervention (PAX GBG) in Estonia: A Matched-pair Cluster-randomized Controlled Trial

National Institute for Health Development, Estonia0 sites708 target enrollmentStarted: May 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
708
Primary Endpoint
Change in children's social and emotional well-being

Study Overview

Brief Summary

The aim of this study is to measure the impact of the intervention (PAX GBG) in Estonian-language 1st grade classrooms on students' mental health and behaviour, and teacher's self-efficacy.

Detailed Description

2-year, matched-pair, cluster-randomized controlled trial with a intervention and wait-list control arm is conducted during school years 2016/17 and 2017/18. 42 volunteering schools were matched to pairs. One school in each pair was randomly selected to receive the PAX GBG or continue their normal activities without intervention. After a post-test assessment in spring 2018 the control group teachers are trained and supported to implement PAX GBG.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
6 Years to 8 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •All schools with first grade classrooms and Estonian-language as instruction language in Estonia were qualified to take part of the study if they did fit the inclusion criteria.
  • •Schools were suitable to participate if they:
  • •Had equal to or more than 13 pupils in the first grade classroom in 2016/17 school term;
  • •Did not implement any other evidence-based program in basic school stage 1 (grades 1-3), (for example KiVa bullying prevention program);
  • •Did not already implement PAX GBG;
  • •Had at least one first grade teacher who volunteers to participate for the whole study period of two years.

Exclusion Criteria

  • •Schools for children with special educational needs and schools with Russian language as instruction language were excluded.
  • •Schools with single-sex classrooms were excluded.

Arms & Interventions

PAX Good Behavior Game

Experimental

The intervention is delivered by teachers within the normal school curriculum. Teachers from intervention classes completed 3-day training and were supported by the mentor, who visited their class during the 2016/17 school year and provided counseling via e-mail and phone. During the second year (2017/18) teachers could use the PAX GBG methods, but they did not receive additional support from the mentors.

Intervention: PAX Good Behavior Game (Behavioral)

Waitlist control group

No Intervention

Control group continue their normal activities without intervention. After a post-test assessment in spring 2018 the control group teachers will be trained and supported to implement PAX GBG.

Outcomes

Primary Outcomes

Change in children's social and emotional well-being

Time Frame: Baseline, 7 months post-baseline and 19 months post-baseline

Children's social and emotional well-being will be measured by the teacher-completed Strengths and Difficulties Questionnaire with impact supplement (SDQ; Goodman, 1999) and parent-rated Strengths and Difficulties Questionnaire (Goodman, 1997).

Secondary Outcomes

  • Change in symptoms of attention deficit hyperactivity disorder (ADHD) among the children(Baseline, 7 months post-baseline and 19 months post-baseline)
  • Change in teachers' sense of efficacy(Baseline, 7 months post-baseline and 19 months post-baseline)
  • Change in children's behavioral inhibition(Baseline, 7 months post-baseline)
  • Change in classroom behavior(Baseline, 7 months post-baseline and 19 months post-baseline)

Investigators

Sponsor
National Institute for Health Development, Estonia
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Karin Streimann

Principal Investigator

National Institute for Health Development, Estonia

Similar Trials